| Literature DB >> 28838184 |
Allen S Craig1, Rustam Haydarov2, Helena O'Malley3, Michael Galway4, Halima Dao5, Ngashi Ngongo5, Marie Therese Baranyikwa6, Savita Naqvi5, Nima S Abid7, Carol Pandak8, Amy Edwards8.
Abstract
The legacy of polio in Africa goes far beyond the tragedies of millions of children with permanent paralysis. It has a positive side, which includes the many well-trained polio staff who have vaccinated children, conducted surveillance, tested stool specimens in the laboratories, engaged with communities, and taken care of polio patients. This legacy also includes support for routine immunization services and vaccine introductions and campaigns for other diseases. As polio funding declines, it is time to take stock of the resources made available with polio funding in Africa and begin to find ways to keep some of the talented staff, infrastructure, and systems in place to work on new public health challenges. The partnerships that helped support polio eradication will need to consider funding to maintain and to strengthen routine immunization services and other maternal, neonatal, and child health programs in Africa that have benefitted from the polio eradication infrastructure.Entities:
Keywords: Africa; Polio; legacy; transition
Mesh:
Year: 2017 PMID: 28838184 PMCID: PMC5853432 DOI: 10.1093/infdis/jix034
Source DB: PubMed Journal: J Infect Dis ISSN: 0022-1899 Impact factor: 5.226
External Funding Requirements in Polio-Endemic and Highest-Risk Countries, Excluding Program Support Costs—2015 (All Figures in US$ Millions)
| Subregion and country | AFP surveillance | Social mobilization | Technical assistance | OPV | Operational costs | Total costs |
|---|---|---|---|---|---|---|
| West/Central Africa | ||||||
| Nigeria | 16.32 | 26.55 | 74.84 | 55.89 | 114.41 | 288.02 |
| Chad | 1.27 | 2.73 | 7.96 | 1.61 | 2.09 | 15.66 |
| Cameroon | 0.41 | 2.73 | 0.57 | 3.29 | 3.23 | 10.23 |
| Niger | 0.59 | 0.58 | 1.78 | 2.52 | 4.62 | 10.09 |
| Mali | 0.25 | 0.21 | 0.14 | 2.39 | 3.23 | 6.22 |
| Burkina Faso | 0.27 | 0.16 | 0.26 | 1.13 | 1.61 | 3.43 |
| Benin | 0.18 | 0.21 | 0.26 | 1.18 | 1.65 | 3.47 |
| Guinea | 0.18 | 0.15 | 0.09 | 1.07 | 1.51 | 2.99 |
| Cote D'Ivoire | 0.29 | 0.22 | 1.09 | 1.38 | 1.61 | 4.59 |
| Central African Republic | 0.47 | 0.71 | 0.63 | 0.44 | 0.76 | 3.01 |
| Democratic Republic of Congo | 2.25 | 2.45 | 11.43 | 0.91 | 3.63 | 20.67 |
| Angola | 1.9 | 0.13 | 10.08 | 0.3 | 0.07 | 12.48 |
| Liberia | 0.23 | 0.22 | 0.49 | 0.34 | 0.91 | 2.19 |
| Gabon | 0.09 | 0.3 | 0.28 | 0.1 | 0.2 | 0.97 |
| Equatorial Guinea | 0.04 | 0.18 | 0.15 | 0.05 | 0.3 | 0.72 |
| Congo | 0.14 | 0.28 | 0.34 | 0.37 | 0.73 | 1.86 |
| Sierra Leone | 0.23 | 0.37 | 0.44 | 0.52 | 1.07 | 2.63 |
| Senegal | 0.32 | 0.16 | 0.16 | 0.46 | 0.46 | 1.56 |
| Horn of Africa | ||||||
| Somalia | 2.42 | 5.06 | 7.35 | 1.87 | 6.09 | 22.79 |
| Ethiopia | 3.06 | 1.58 | 3.19 | 2.32 | 6.66 | 16.81 |
| Kenya | 0.44 | 0.9 | 1.87 | 1.21 | 4.23 | 8.65 |
| South Sudan | 1.27 | 1.14 | 4.43 | 0.99 | 4.12 | 11.94 |
| Sudan | 1.27 | 0.23 | 0.62 | 0.79 | 1.82 | 4.72 |
| Uganda | 0.4 | 0.1 | 0.8 | 0.64 | 1.08 | 3.02 |
| Yemen | 0.19 | 0.43 | 0.19 | 1.45 | 2.09 | 4.35 |
| Middle East | ||||||
| Egypt | 0.38 | 0.3 | 0.38 | 1.54 | 0.4 | 3 |
| Total (percentage) | 34.86 (8%) | 48.08 (10%) | 129.82 (28%) | 84.76 (18%) | 168.58 (36%) | 466.07 (100%) |
Abbreviations: AFP, acute flaccid paralysis; OPV, oral polio vaccine.
Figure 1.Estimated costs for polio eradication 2013–2019, by activity ($US millions, not including India self-funded costs). Abbrevations: AFP, acute flaccid paralysis; IPV, inactivated polio vaccine; OPV, oral polio vaccine; QI, quality improvement; R&D, research and development; RI, routine immunization.
Summary of Confirmed Funding Against Global Vaccine Summit Commitments (All Figures in US$ Millions)
| G7 and European Commission | Committed funding at the April 2013 Vaccine Summitk | Confirmed funding against the Global Polio Eradication Initiative financial resource requirements as of 1 April 2016 |
|---|---|---|
| Canadaa | 243.53 | 197.97 |
| European Commission | 6.5 | 27.06 |
| Germanyb | 151.7 | 111.67 |
| Japanc | 9.7 | 43.5 |
| United Kingdomd | 457 | 480.67 |
| USAe | 90.6 | 401.84 |
| Non-G7 Office for Economic Development and Coorperation | ||
| Australiaf | 34.55 | 55.24 |
| Finland | 0.53 | 0.53 |
| Ireland | 6.5 | 6.36 |
| Luxembourg | 0.7 | 3.21 |
| Norwayg | 252.45 | 211.93 |
| Other donor countries | ||
| Brunei Darussalam | 0.05 | 0.05 |
| Isle of Man | 0.14 | 0.05 |
| Liechtenstein | 0.02 | 0.08 |
| Monaco | 0.35 | 0.95 |
| Saudi Arabia | 15 | 12.35 |
| Private sector/Nongovernmental donors | ||
| Al Ansari Exchange | 1 | 1 |
| Abu Dhabi-Crown Princeh | 120 | 53.49 |
| Bill & Melinda Gates Foundationi | 1 800.00 | 1 108.39 |
| Korean Foundation for International Healthcare/Community Chest of Korea | 1 | 3 |
| Private philanthropists/high net worth individuals | 335 | 89.68 |
| Rotary Internationali | 76.81 | 344.53 |
| United Nations Foundation | 0.75 | 0.8 |
| Multilateral sector | ||
| The Vaccine Alliance (Gavi)/International Finance Facility for Immunization | 24 | 25.21 |
| Islamic Development Bank/Government of Pakistan | 227 | 225.46 |
| United Nations Children’s Fund | 64.5 | 56.08 |
| World Bank (Grant to Afghanistan) | 10 | 11 |
| World Bank Investment Partnership, Bank Portion | 50 | 50 |
| World Health Organization | 4.27 | 12.77 |
| Domestic resources | ||
| Angola | 7.3 | 6.54 |
| Bangladesh | 10 | 10 |
| Nepal | 0.9 | 0.67 |
| Nigeriaj | 40 | 239.37 |
| TOTAL | 4 041.85 | 3 791.45 |
aCanada pledged Can$ 250 million for the 2013–2018 period. Canada also provided an additional Can$3 million for the 2013–2014 Horn of Africa outbreak. Contributions do not include approximately Can$28.6 million for activities in Pakistan, Nigeria, and Ukraine that lie outside the Global Polio Eradication Initiative (GPEI) budget but support the overall goal of polio eradication.
bGermany also provided more than €13 million in 2013–2014 for the Middle East outbreak in addition to current disbursements under its €105 million 2013–2017 pledge.
cSince 2011, Japan has supplemented its traditional grant financing with innovative financing in partnership with the Bill & Melinda Gates Foundation. Under this loan conversion model, Japan has provided development assistance loans to Nigeria (approximately US$70 million, 2015–2016) for vaccine and operational costs. If performance criteria are met, the BMGF will repay the loan credit to the Japan International Cooperation Agency on behalf of the Nigerian government, in effect converting the loan to a grant.
dThe United Kingdom committed £300 million to polio eradication for the 2013–2018 period, comprised of “core” and “match” funds. The figures for 2016–2018 include £28 million in “match” funds as well as £27 million to Gavi for inactivated polio vaccine (IPV) procurement. The United Kingdom also provided an additional £13.8 million for the 2013–2014 Horn of Africa and Middle East outbreaks.
eUnited States figures reflect the actual amount received directly by the 2 implementing agencies, consistent with the United Nations revenue recognition policy. The fiscal year 2016 Congressional allocation is US$228 million. The 2016 figure represents disbursements to WHO and UNICEF from the US Centers for Disease Control and Prevention and United States Agency for International Development against the GPEI’s 2016 budget to date.
fAustralia’s figures include funding received for the 2013–2015 period under 2 commitments: 2011–2015 (Aus$50 million) and 2015–2019 (Aus$36 million).
gNorway’s figures reflect all confirmed funding to Gavi (2013–2019) and funding to WHO (2013–2015).
hAbu Dhabi-Crown Prince figures include funds via the UAE Pakistan Assistance Programme.
iIn 2013, Rotary pledged up to US$175 million for the 2013–2018 period, which will be matched by the Bill & Melinda Gates Foundation. Contributions under this scheme are included in Rotary’s figures. Rotary’s contributions to the GPEI are through the Rotary Foundation.
jNigeria’s figures include domestic resources from loans from the World Bank (US$85.6 million) and the Japan International Cooperation Agency loan conversion (US$70.3 million).
kOnly includes donors who pledged funds at the Vaccine Summit. See www.polioeradication.org/financing.aspx for additional information on contributions, including those that are not against the GPEI budget (non-Financial Resource Requirement report).